The Impact of Polypharmacy in Fibromyalgia Patients: A Ticking Time Bomb

Authors

Keywords:

fibromialgia

Downloads

Download data is not yet available.

References

Rivera J, Vallejo MA. Fibromyalgia is associated to receiving chronic medications beyond appropriateness: a cross-sectional study. Rheumatology International [Internet]. 2016 Sep 23;36(12):1691–9. Available from: https://doi.org/10.1007/s00296-016-3568-2

Mascarenhas RO, Souza MB, Oliveira MX, et al. Efficacy and safety of pharmacological therapies for fibromyalgia: a systematic review and network meta-analysis. Lancet Rheumatol. 2021;3(9):e645-e658. https://pubmed.ncbi.nlm.nih.gov/33104162/

Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, et al. EULAR revised recommendations for the management of fibromyalgia. Annals of the Rheumatic Diseases [Internet]. 2016 Jul 4;76(2):318–28. Available from: https://air.unimi.it/handle/2434/640542

Vincent A, Whipple MO, McAllister SJ, Aleman KM, St Sauver JL. A cross-sectional assessment of the prevalence of multiple chronic conditions and medication use in a sample of community-dwelling adults with fibromyalgia in Olmsted County, Minnesota. BMJ Open [Internet]. 2015 Mar 1;5(3):e006681. Available from: https://bmjopen.bmj.com/content/5/3/e006681.long

Published

2026-02-13

How to Cite

1.
Contreras Carvajal KY, Contreras K, Therán J. The Impact of Polypharmacy in Fibromyalgia Patients: A Ticking Time Bomb. Rev. cuba. de Reumatol. [Internet]. 2026 Feb. 13 [cited 2026 May 1];28:e1428. Available from: https://revreumatologia.sld.cu/index.php/reumatologia/article/view/1428

Issue

Section

Letters to the editor